References
- Roopashree MR, Gondhalekar RV, Shashikanth MC, et al. Pathogenesis of oral lichen planus – a review. J Oral Pathol Med. 2010;39:729–734.
- Mortazavi H, Baharvand M, Mehdipour M. Oral potentially malignant disorders: an overview of more than 20 entities. J Dent Res Dent Clin Dent Prospects. 2014;8:6–14.
- Lavanya N, Rao UK, Jayanthi P, et al. Oral lichen planus: an update on pathogenesis and treatment. J Oral Maxillofac Pathol. 2011;15:127–132.
- Ryan K, Hegarty AM, Hodgson T. Aetiology, diagnosis and treatment of oral lichen planus. Brit J Hospital Med. 2014;75:492–496.
- Enomoto A, Sato E, Yasuda T, et al. Intraepithelial CD8+ lymphocytes as a predictive diagnostic biomarker for the remission of oral lichen planus. Human Pathol. 2018;74:43–53.
- Agha-Hosseini F, Mirzaii-Dizgah I, Farmanbar N, et al. Oxidative stress status and DNA damage in saliva of human subjects with oral lichen planus and oral squamous cell carcinoma. J Oral Pathol Med. 2012;41:736–740.
- Abdolsamadi H, Rafieian N, Goodarzi MT, et al. Levels of salivary antioxidant vitamins and lipid peroxidation in patients with oral lichen planus and healthy individuals. Chonnam Med J. 2014;50:58–62.
- Akram Z, Abduljabbar T, Vohra F, et al. Efficacy of low-level laser therapy compared to steroid therapy in the treatment of oral lichen planus: a systematic review. J Oral Pathol Med. 2018;47:11–17.
- Han X, Zhang J, Tan Y, et al. Probiotics: A non-conventional therapy for oral lichen planus. Arch Oral Biol. 2017;81:90–96.
- Bradford PG. Curcumin and obesity. Biofactors. 2013;39:78–87.
- Noorafshan A, Ashkani-Esfahani S. A review of therapeutic effects of curcumin. CPD. 2013;19:2032–2046.
- Shehzad A, Rehman G, Lee YS. Curcumin in inflammatory diseases. Biofactors. 2013;39:69–77.
- Anthwal A, Thakur BK, Rawat MS, et al. Synthesis, characterization and in vitro anticancer activity of C-5 curcumin analogues with potential to inhibit TNF-alpha-induced NF-kappaB activation. BioMed Res Int. 2014;2014:524161.
- Singh SP, Sharma M, Gupta PK. Enhancement of phototoxicity of curcumin in human oral cancer cells using silica nanoparticles as delivery vehicle. Lasers Med Sci. 2014;29:645–652.
- Kanai M. Therapeutic applications of curcumin for patients with pancreatic cancer. World J Gastroenterol. 2014;20:9384–9391.
- Cho JA, Park E. Curcumin utilizes the anti-inflammatory response pathway to protect the intestine against bacterial invasion. Nutr Res Pract. 2015;9:117–122.
- Xia F, Chun Z, Dong-bo L, et al. The clinical applications of curcumin: current state and the future. Curr Pharmaceut Design. 2013;19:2011–2031.
- Chainani-Wu N, Silverman Jr S, Reingold A, et al. A randomized, placebo-controlled, double-blind clinical trial of curcuminoids in oral lichen planus. Phytomedicine. 2007;14:437–446.
- Chainani-Wu N, Madden E, Lozada-Nur F, et al. High-dose curcuminoids are efficacious in the reduction in symptoms and signs of oral lichen planus. J Am Acad Dermatol. 2012;66:752–760.
- Kia SJ, Shirazian S, Mansourian A, et al. Comparative efficacy of topical curcumin and triamcinolone for oral lichen planus: a randomized, controlled clinical trial. J Dentist (Tehran, Iran). 2015;12:789–796.
- Amirchaghmaghi M, Pakfetrat A, Delavarian Z, et al. Evaluation of the efficacy of curcumin in the treatment of oral lichen planus: a randomized controlled trial. J Clin Diagn Res. 2016;10:Zc134–Zc137.
- Thomas AE, Varma B, Kurup S, et al. Evaluation of efficacy of 1% curcuminoids as local application in management of oral lichen planus - interventional study. J Clin Diagnost Res. 2017;11:ZC89–ZC93.
- Nosratzehi T, Arbabi-Kalati F, Hamishehkar H, et al. Comparison of the effects of curcumin mucoadhesive paste and local corticosteroid on the treatment of erosive oral lichen planus lesions. J Natl Med Assoc. 2018;110:92–97.
- Singh V, Pal M, Gupta S, et al. Turmeric - a new treatment option for lichen planus: a pilot study. Natl J Maxillofac Surg. 2013;4:198–201.
- Kia SJ, Basirat M, Estakhr L. The effect of oral curcumin on pain and clinical appearance of oral lichen planus. J Dentomaxillofac Radiol Pathol Surg. 2017;6:1–7.
- Sumanth P, Savita S, Chinmaya BR, et al. The magic of herbal curcumin therapy in recurrent oral lichen planus. Am J Ethnomed. 2014;1:96–101.
- Silverman S, Jr., Gorsky M, Lozada-Nur F. A prospective follow-up study of 570 patients with oral lichen planus: persistence, remission, and malignant association. Oral Surg Oral Med Oral Pathol. 1985;60:30–34.
- Alrashdan MS, Cirillo N, McCullough M. Oral lichen planus: a literature review and update. Arch Dermatol Res. 2016;308:539–551.
- Zhang Y, Lin M, Zhang S, et al. NF-kappaB-dependent cytokines in saliva and serum from patients with oral lichen planus: a study in an ethnic Chinese population. Cytokine. 2008;41:144–149.
- Lysitsa S, Samson J, Gerber-Wicht C, et al. COX-2 expression in oral lichen planus. Dermatol (Basel, Switzerland). 2008;217:150–155.
- Cortes-Ramirez DA, Rodriguez-Tojo MJ, Gainza-Cirauqui ML, et al. Overexpression of cyclooxygenase-2 as a biomarker in different subtypes of the oral lichenoid disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:738–743.
- Singh P, Grover J, Byatnal AA, et al. Elucidating the role of cyclooxygenase-2 in the pathogenesis of oral lichen planus - an immunohistochemical study with supportive histochemical analysis. J Oral Pathol Med. 2017;46:381–386.
- Esatbeyoglu T, Huebbe P, Ernst IM, et al. Curcumin – from molecule to biological function. Angew Chem Int Ed. 2012;51:5308–5332.
- Rekha VR, Sunil S, Rathy R. Evaluation of oxidative stress markers in oral lichen planus. J Oral Maxillofac Pathol. 2017;21:387–393.
- Darczuk D, Krzysciak W, Vyhouskaya P, et al. Salivary oxidative status in patients with oral lichen planus. J Physiol Pharmacol. 2016;67:885–894.
- Sreejayan RMN. Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol. 1997;49:105–107.
- Joe B, Lokesh BR. Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim Biophys Acta. 1994;1224:255–263.
- Joe B, Vijaykumar M, Lokesh BR. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr. 2004;44:97–111.
- Chakravarti N, Kadara H, Yoon DJ, et al. Differential inhibition of protein translation machinery by curcumin in normal, immortalized, and malignant oral epithelial cells. Cancer Prevent Res. 2010;3:331–338.
- Sandur SK, Ichikawa H, Pandey MK, et al. Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radical Biol Med. 2007;43:568–580.
- Yang H, Huang S, Wei Y, et al. Curcumin enhances the anticancer effect of 5-fluorouracil against gastric cancer through down-regulation of COX-2 and NF-kappaB signaling pathways. J Cancer. 2017;8:3697–3706.
- Yadav VS, Mishra KP, Singh DP, et al. Immunomodulatory effects of curcumin. Immunopharmacol Immunotoxicol. 2005;27:485–497.
- Awad AS, El-Sharif AA. Curcumin immune-mediated and anti-apoptotic mechanisms protect against renal ischemia/reperfusion and distant organ induced injuries. Int Immunopharmacol. 2011;11:992–996.
- Srivastava RM, Singh S, Dubey SK, et al. Immunomodulatory and therapeutic activity of curcumin. Int Immunopharmac. 2011;11:331–341.
- Seyedzadeh MH, Safari Z, Zare A, et al. Study of curcumin immunomodulatory effects on reactive astrocyte cell function. Int Immunopharmacol. 2014;22:230–235.
- Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001;21:2895–2900.
- Liu W, Zhai Y, Heng X, et al. Oral bioavailability of curcumin: problems and advancements. J Drug Target. 2016;24:694–702.